Ex-FDA commish Scott Gottlieb makes a quick jump back onto the money side of biotech

Ex-FDA commish Scott Gottlieb makes a quick jump back onto the money side of biotech

Source: 
Endpoints
snippet: 

Well, that didn't take long.

Just a little more than a month after Scott Gottlieb’s surprise exit at the FDA, the former commish is back on the money side of the industry he had been in charge of regulating for 2 years. He’s rejoining New Enterprise Associates as a full-time investing partner, where he expects to start backing biotech startups and sitting on boards again.